Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China · Delayed Price · Currency is CNY 7.62
-0.05 (-0.65%)
Apr 22, 2026, 10:05 AM CST
SHE:002566 Revenue
In the year 2025, Jilin Jian Yisheng Pharmaceutical had annual revenue of 640.17M CNY, down -4.23%. Jilin Jian Yisheng Pharmaceutical had revenue of 163.98M in the quarter ending December 31, 2025, with 0.66% growth.
Revenue
640.17M
Revenue Growth
-4.23%
P/S Ratio
3.97
Revenue / Employee
386.58K
Employees
1,656
Market Cap
2.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 640.17M | -28.30M | -4.23% |
| Dec 31, 2024 | 668.47M | -185.20M | -21.69% |
| Dec 31, 2023 | 853.66M | 23.62M | 2.85% |
| Jan 1, 2023 | 830.04M | -47.89M | -5.45% |
| Jan 1, 2022 | 877.93M | 35.34M | 4.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.07B |
| Shandong Sito Bio-technology | 954.76M |
| Zhejiang East Asia Pharmaceutical | 831.56M |
| Guangdong VTR Bio-Tech | 830.87M |
| Guiyang Xintian Pharmaceutical | 749.72M |
| Hubei Goto Biopharm | 626.28M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Shanghai Hile Bio-Technology | 246.35M |